This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return ...
LONDON (Alliance News) - Shares in Consort Medical PLC fell early Tuesday after the drug delivery company warned that delays to Mylan NV's Wixela inhaler for lung disease treatment will hit annual ...
HERTFORDSHIRE, England, and PITTSBURGH, May 18, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced four scientific abstracts from the Wixela™ Inhub™ ...
NEW YORK — The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan’s version in three ...
HERTFORDSHIRE, England and PITTSBURGH, Jan. 31, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the U.S. Food and Drug Administration (FDA) approval of Wixela™ Inhub™ (fluticasone ...
DEAR PEOPLE’S PHARMACY: My father has severe COPD. The doctors at the Department of Veterans Affairs hospital prescribed Wixela, in addition to several other inhalers. Soon, he began to notice ...
The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan’s version in three strengths for ages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback